 The study will involve a 2 phases of treatment: an acute treatment phase of 3-9 weeks duration and a maintenance treatment phase, lasting 52 weeks. In the initial 3 weeks of the acute treatment phase the study will be randomised, double blind and sham-controlled with three arms: 